scispace - formally typeset
C

Carlos Fernandes

Researcher at University of Porto

Publications -  45
Citations -  2143

Carlos Fernandes is an academic researcher from University of Porto. The author has contributed to research in topics: Medicine & Antioxidant. The author has an hindex of 17, co-authored 39 publications receiving 1721 citations.

Papers
More filters
Journal ArticleDOI

Establishment and cryptic transmission of Zika virus in Brazil and the Americas

Nuno R. Faria, +78 more
- 15 Jun 2017 - 
TL;DR: The origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly and other birth defects as mentioned in this paper.
Journal ArticleDOI

Superparamagnetic MFe2O4 (M = Fe, Co, Mn) Nanoparticles: Tuning the Particle Size and Magnetic Properties through a Novel One-Step Coprecipitation Route

TL;DR: In this article, superparamagnetic ferrite nanoparticles (MFe2O4, where M = Fe, Co, Mn) were synthesized through a novel one-step aqueous coprecipitation method based on the use of a new type of alkaline agent: the alkanolamines isopropanolamine and diisopropanoamine.
Journal Article

Estabelecimento e transmissão crítica do vírus Zika no Brasil e nas Américas/Establishment and cryptic transmission of Zika virus in Brazil and the Americas

TL;DR: Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZikV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas.
Journal ArticleDOI

Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection

TL;DR: HBV-specific T cells with different target specificities are characterised by distinct phenotypical and functional profiles, which have direct implications for the design of immunological studies in HBV infection, and are potentially relevant for informing immunotherapeutic approaches to induce functional cure.
Journal ArticleDOI

Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors

TL;DR: Computational docking studies provided insights into enzyme-inhibitor interactions and a rationale for the observed selectivity and potency, and compound 27 stands out due to its favorable toxicological profile and physicochemical properties, which pointed toward blood-brain barrier permeability, thus being a valid candidate for subsequent animal studies.